Honeywell announced today that it has signed a definitive agreement to acquire the Seelze, Germany-based laboratory research chemicals business from Sigma-Aldrich for approximately 105 million euro.
The acquired Sigma-Aldrich business develops and manufactures high-purity research chemicals and other materials used in new drug discovery, medical diagnostic testing and other laboratory applications. The agreement is subject to customary closing conditions, including regulatory review.
“This acquisition allows Honeywell to offer laboratory customers a more complete product line, and builds on our already strong portfolio of Burdick & Jackson® high-purity solvents and reagents adding some of the industry’s most well-known and respected brands,” said Darius Adamczyk, president and CEO of Honeywell Performance Materials and Technologies. “The acquisition will enable Honeywell to offer a broader line of inorganic chemicals and solvents for demanding applications ranging from pharmaceutical drug discovery to medical diagnostic testing.”
Honeywell will acquire three global brands:
- Fluka® chemicals and reagents used for biochemical research and other chemical and pharmaceutical applications.
- Hydranal® Karl Fischer titration reagents used by laboratories to measure moisture content in liquids and solids.
- Chromasolv® high-purity solvents for chromatography, a technique used to separate and analyze complex mixtures.
All three product brands are globally recognized for their quality and lot-to-lot consistency, which is critical for a range of applications including drug synthesis, food, environmental, chemical and forensic testing.